NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 57.74

-2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (253)	8/8/2007 5:41:02 PM
From: zax	of 507

Nektar narrows Q2 loss by 56% Wednesday August 8, 5:13 pm ET Nektar Therapeutics said Wednesday it had a second quarter loss of $27.5 million or 30 cents a share, narrowed from a loss of $62.8 million or 70 cents a share in the same period last year. San Carlos-based Nektar (NASDAQ:NKTR) said the figure included $4.4 million in stock-based compensation and $7.7 million related to a work force reduction charge. Revenue for the quarter was $65.9 million, up from $60.2 million in the second quarter of 2006. At the end of the quarter, the company's cash, cash equivalents, and short-term investments were $406.8 million. Published August 8, 2007 by the Silicon Valley / San Jose Business Journal

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next